Suppr超能文献

新冠大流行期间和之前美国儿童和青少年过敏和哮喘的流行率差异。

Differences in the prevalence of allergy and asthma among US children and adolescents during and before the COVID-19 pandemic.

机构信息

Department of Child and Adolescent Health, School of Public Health, Guangdong Province, Guangdong Pharmaceutical University, Guangzhou, 510006, China.

Department of Nutrition and Food Health, School of Public Health, Guangdong Province, Guangdong Pharmaceutical University, Guangzhou, 510006, China.

出版信息

BMC Public Health. 2024 Aug 6;24(1):2124. doi: 10.1186/s12889-024-19639-8.

Abstract

BACKGROUND

The increasing prevalence of allergies and asthma has led to a growing global socioeconomic burden. Since the outbreak of the COVID-19 pandemic, the health and lifestyles of children and adolescents have changed dramatically. It's unclear how this shift impacted allergy and asthma, with limited studies addressing this question. We aim to explore the difference of the prevalence of allergies and asthma among US children and adolescents during and before the COVID-19 pandemic using a nationally representative sample of US children and adolescents.

METHODS

This cross-sectional study included 31,503 participants in the National Health Interview Survey (NHIS) between 2018 and 2021. Allergies and asthma were defined on an affirmative response in the questionnaire by a parent or guardian. Chi-square tests were used to compare baseline characteristics with allergies and asthma for categorical variables. Differences in prevalence during and before the COVID-19 pandemic were estimated with weighted logistic regression, adjusting for demographic factors. Interaction analyses explored variations across strata.

RESULTS

In US children and adolescents aged 0 to 17, prevalence of any allergy was 26.1% (95% CI, 24.8%- 27.4%) in 2018 and 27.1% (95% CI, 25.9%- 28.2%) in 2021. Thereinto, in 2018, prevalence of respiratory allergies, food allergies and skin allergies were 14.0% (95% CI, 13.1%- 15.0%), 6.5% (95% CI, 5.8%- 7.1%) and 12.6% (95% CI, 11.6%- 13.5%), respectively, and in 2021, 18.8% (95% CI, 17.8%- 19.9%), 5.8% (95% CI, 5.2%- 6.4%) and 10.7% (95% CI, 9.9%- 11.5%), respectively. And prevalence of asthma was 11.1% (95% CI, 10.5%- 11.7%) in 2018-2019 and 9.8% (95% CI, 9.2%- 10.4%) in 2020-2021. Prevalence of respiratory allergies, skin allergies and asthma during and before the COVID-19 pandemic in children and adolescents had statistically significant differences. The differences persisted after adjusting for demographic and socioeconomic variables.

CONCLUSION

Prevalence of respiratory allergies increased and the prevalence of both skin allergies and asthma decreased among US children and adolescents during the COVID-19 pandemic compared with the pre-COVID-19 pandemic. Further research is required to explore the association between allergic diseases and the pandemic, with a particular emphasis on the impact of lifestyle changes resulting from measures to prevent COVID-19 infection.

摘要

背景

过敏和哮喘的患病率不断上升,导致了日益严重的全球社会经济负担。自 COVID-19 大流行爆发以来,儿童和青少年的健康和生活方式发生了巨大变化。目前尚不清楚这种转变如何影响过敏和哮喘,有限的研究对此进行了探讨。我们旨在使用美国儿童和青少年的全国代表性样本,探讨 COVID-19 大流行期间和之前美国儿童和青少年过敏和哮喘患病率的差异。

方法

本横断面研究纳入了 2018 年至 2021 年期间国家健康访谈调查(NHIS)中的 31503 名参与者。过敏和哮喘通过父母或监护人在问卷中给出肯定回答来定义。卡方检验用于比较有和无过敏和哮喘的基线特征的分类变量。使用加权逻辑回归估计 COVID-19 大流行期间和之前的患病率差异,调整人口统计学因素。交互分析探索了不同分层的差异。

结果

在美国 0 至 17 岁的儿童和青少年中,2018 年任何过敏的患病率为 26.1%(95%CI,24.8%-27.4%),2021 年为 27.1%(95%CI,25.9%-28.2%)。其中,2018 年呼吸道过敏、食物过敏和皮肤过敏的患病率分别为 14.0%(95%CI,13.1%-15.0%)、6.5%(95%CI,5.8%-7.1%)和 12.6%(95%CI,11.6%-13.5%),2021 年分别为 18.8%(95%CI,17.8%-19.9%)、5.8%(95%CI,5.2%-6.4%)和 10.7%(95%CI,9.9%-11.5%)。哮喘的患病率在 2018-2019 年为 11.1%(95%CI,10.5%-11.7%),在 2020-2021 年为 9.8%(95%CI,9.2%-10.4%)。COVID-19 大流行期间和之前儿童和青少年的呼吸道过敏、皮肤过敏和哮喘患病率存在统计学差异。在调整人口统计学和社会经济变量后,这些差异仍然存在。

结论

与 COVID-19 大流行前相比,美国儿童和青少年在 COVID-19 大流行期间呼吸道过敏的患病率增加,皮肤过敏和哮喘的患病率降低。需要进一步研究以探讨过敏性疾病与大流行之间的关联,特别强调预防 COVID-19 感染措施导致的生活方式变化的影响。

相似文献

2
Association of Food Allergy and Other Allergic Conditions With Autism Spectrum Disorder in Children.
JAMA Netw Open. 2018 Jun 1;1(2):e180279. doi: 10.1001/jamanetworkopen.2018.0279.
3
Racial, Ethnic, and Socioeconomic Differences in Food Allergies in the US.
JAMA Netw Open. 2023 Jun 1;6(6):e2318162. doi: 10.1001/jamanetworkopen.2023.18162.
4
Trends in allergy prevalence among children aged 0-17 years by asthma status, United States, 2001-2013.
J Asthma. 2016;53(4):356-62. doi: 10.3109/02770903.2015.1126848. Epub 2016 Jan 22.
6
Food allergy among low birthweight children in a national survey.
Matern Child Health J. 2013 Jan;17(1):165-71. doi: 10.1007/s10995-012-0960-8.
7
Association Between Atopic Disease and Anemia in US Children.
JAMA Pediatr. 2016 Jan;170(1):29-34. doi: 10.1001/jamapediatrics.2015.3065.
8
Prevalence and Severity of COVID-19 among Pediatric Patients with Atopy: A Cross-sectional Study in Kerman, Southeast Iran.
Iran J Allergy Asthma Immunol. 2024 Apr 7;23(2):127-138. doi: 10.18502/ijaai.v23i2.15317.
9
Tree nut allergy, egg allergy, and asthma in children.
Clin Pediatr (Phila). 2011 Feb;50(2):133-9. doi: 10.1177/0009922810384720. Epub 2010 Nov 22.

本文引用的文献

1
Atopic outcomes at 2 years in the CORAL cohort, born in COVID-19 lockdown.
Pediatr Allergy Immunol. 2023 Sep;34(9):e14013. doi: 10.1111/pai.14013.
4
Influence of the COVID-19 Pandemic on the Prevalence Pattern of Allergens.
Int Arch Allergy Immunol. 2023;184(1):43-53. doi: 10.1159/000526892. Epub 2022 Oct 24.
5
Impact of COVID-19 mitigation strategies on asthma hospitalizations in Brazil.
J Allergy Clin Immunol Glob. 2022 Aug;1(3):106-111. doi: 10.1016/j.jacig.2022.03.004. Epub 2022 Apr 30.
6
The differential impact of air pollutants on acute urticaria and chronic urticaria: a time series analysis.
Environ Sci Pollut Res Int. 2023 Feb;30(6):14656-14662. doi: 10.1007/s11356-022-22659-9. Epub 2022 Sep 26.
7
Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives.
Cell Commun Signal. 2022 Aug 29;20(1):131. doi: 10.1186/s12964-022-00948-7.
8
Impact of lockdowns on paediatric asthma hospital presentations over three waves of COVID-19 pandemic.
Allergy Asthma Clin Immunol. 2022 Jun 16;18(1):53. doi: 10.1186/s13223-022-00691-1.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验